Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits
Xiaowei Zhang(Lanzhou University Second Hospital), Tong Liu(Second Hospital of Tianjin Medical University), Yajuan Yang(Second Hospital of Tianjin Medical University), Zhiwei Zhang(Second Hospital of Tianjin Medical University), Xue Liang(Chongqing Normal University), Jian Li(National Clinical Research), Xinghua Wang(Second Hospital of Tianjin Medical University), Guangping Li(Qingdao University), Ning Jiang(Tianjin University of Sport), Gary Tse(Observational & Pragmatic Research Institute), Yungang Zhao(Tianjin University of Sport), Jiuchun Qiu(Second Hospital of Tianjin Medical University)
Cited by 78
Related Papers
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
|Signal Transduction and Targeted Therapy|2022|1.5k
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
|Circulation|2019|346